ATC code N07
ATC code N07 Other nervous system drugs is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2][3] Subgroup N07 is part of the anatomical group N Nervous system.[4]
| ATC codes |
|---|
| N Nervous system |
| N01 Anesthetics |
| N02 Analgesics |
| N03 Antiepileptics |
| N04 Anti-parkinson drugs |
| N05 Psycholeptics |
| N06 Psychoanaleptics |
| N07 Other nervous system drugs |
| ATCvet only |
| QN51 Products for animal euthanasia |
|
|
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QN07.[5]
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
N07A Parasympathomimetics
N07AA Anticholinesterases
- N07AA01 Neostigmine
- N07AA02 Pyridostigmine
- N07AA03 Distigmine
- N07AA30 Ambenonium
- N07AA51 Neostigmine, combinations
N07AB Choline esters
- N07AB01 Carbachol
- N07AB02 Bethanechol
N07AX Other parasympathomimetics
- N07AX01 Pilocarpine
- N07AX02 Choline alfoscerate
- N07AX03 Cevimeline
N07B Drugs used in addictive disorders
N07BA Drugs used in nicotine dependence
- N07BA01 Nicotine
- N07BA03 Varenicline
- N07BA04 Cytisinicline
N07BB Drugs used in alcohol dependence
- N07BB01 Disulfiram
- N07BB02 Calcium carbimide
- N07BB03 Acamprosate
- N07BB04 Naltrexone
- N07BB05 Nalmefene
N07BC Drugs used in opioid dependence
- N07BC01 Buprenorphine
- N07BC02 Methadone
- N07BC03 Levacetylmethadol
- N07BC04 Lofexidine
- N07BC05 Levomethadone
- N07BC06 Diamorphine
- N07BC51 Buprenorphine, combinations
N07C Antivertigo preparations
N07CA Antivertigo preparations
- N07CA01 Betahistine
- N07CA02 Cinnarizine
- N07CA03 Flunarizine
- N07CA04 Acetylleucine
- N07CA52 Cinnarizine, combinations
N07X Other nervous system drugs
N07XX Other nervous system drugs
- N07XX01 Tirilazad
- N07XX02 Riluzole
- N07XX03 Xaliproden
- N07XX04 Sodium oxybate
- N07XX05 Amifampridine
- N07XX06 Tetrabenazine
- N07XX07 Fampridine
- N07XX08 Tafamidis
- N07XX10 Laquinimod
- N07XX11 Pitolisant
- N07XX12 Patisiran
- N07XX13 Valbenazine
- N07XX14 Edaravone
- N07XX15 Inotersen
- N07XX16 Deutetrabenazine
- N07XX17 Arimoclomol
- N07XX59 Dextromethorphan, combinations
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code N07". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QN07". WHO Collaborating Centre for Drug Statistics Methodology.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.